TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 148 filers reported holding TRANSLATE BIO INC in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,382,000 | +179.3% | 376,993 | +67.3% | 2.17% | +146.1% |
| Q1 2021 | $3,717,000 | -10.5% | 225,393 | 0.0% | 0.88% | -28.6% |
| Q4 2020 | $4,154,000 | +59.8% | 225,393 | +18.1% | 1.24% | +46.3% |
| Q3 2020 | $2,599,000 | +77.5% | 190,930 | +6.2% | 0.84% | +68.0% |
| Q4 2019 | $1,464,000 | -59.4% | 179,845 | -50.6% | 0.50% | -63.0% |
| Q3 2019 | $3,610,000 | +60.3% | 364,229 | +104.3% | 1.36% | +60.3% |
| Q2 2019 | $2,252,000 | +31.2% | 178,306 | -22.1% | 0.85% | -0.8% |
| Q4 2018 | $1,717,000 | +13.2% | 228,939 | +50.9% | 0.85% | +37.1% |
| Q3 2018 | $1,517,000 | +499.6% | 151,739 | +658.7% | 0.62% | +428.0% |
| Q2 2018 | $253,000 | – | 20,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |